Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement

M. Froldi, A. Castagna, M. Parma, A. Piona, A. Tedeschi, A. Miadonna, M. Lorini, E. Nobile Orazio, A. Lazzarin

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In this study we evaluated the release of some mediators of inflammatory reactions such as histamine (H), leukotriene B4 (LTB4) leukotriene C4 (LTC4) and prostaglandin D2 (PGD2) in the cerebrospinal fluid (CSF) of 15 patients with acquired immunodeficiency syndrome (AIDS), eight with opportunistic infections of the central nervous system (CNS) and seven without HIV-related neurological pathology, and of 25 HIV-negative control subjects with other neurological diseases. The cerebrospinal LTB4 level was increased in all the AIDS patients (mean 348 pg/ml); the control group revealed normal levels of LTB4 in the CSF (mean 63.2 pg/ml). The PGD2 level in the HIV-positive (mean 264 pg/ml) patients was higher than of the control subjects (mean 50 pg/ml), while low LTC4 levels were found both in the HIV-positive and control groups. We did not find any significant concentration of H in the CSF of either the HIV-positive or the control subjects. These findings may be due to the presence of chronic HIV infection or to the opportunistic infections of the CNS that so often occur in the latest stages of the disease.

Original languageEnglish
Pages (from-to)155-161
Number of pages7
JournalJournal of Neuroimmunology
Volume38
Issue number1-2
DOIs
Publication statusPublished - 1992

Fingerprint

Cerebrospinal Fluid
Central Nervous System
HIV
Leukotriene B4
Prostaglandin D2
Leukotriene C4
Opportunistic Infections
Acquired Immunodeficiency Syndrome
Control Groups
Histamine
HIV Infections
Pathology

Keywords

  • Cerebrospinal fluid
  • Human immunodeficiency virus
  • Leukotriene B

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Clinical Neurology
  • Neurology

Cite this

Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. / Froldi, M.; Castagna, A.; Parma, M.; Piona, A.; Tedeschi, A.; Miadonna, A.; Lorini, M.; Nobile Orazio, E.; Lazzarin, A.

In: Journal of Neuroimmunology, Vol. 38, No. 1-2, 1992, p. 155-161.

Research output: Contribution to journalArticle

Froldi, M. ; Castagna, A. ; Parma, M. ; Piona, A. ; Tedeschi, A. ; Miadonna, A. ; Lorini, M. ; Nobile Orazio, E. ; Lazzarin, A. / Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. In: Journal of Neuroimmunology. 1992 ; Vol. 38, No. 1-2. pp. 155-161.
@article{02584f1b7a3247eeaf9a00b03cc0ed92,
title = "Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement",
abstract = "In this study we evaluated the release of some mediators of inflammatory reactions such as histamine (H), leukotriene B4 (LTB4) leukotriene C4 (LTC4) and prostaglandin D2 (PGD2) in the cerebrospinal fluid (CSF) of 15 patients with acquired immunodeficiency syndrome (AIDS), eight with opportunistic infections of the central nervous system (CNS) and seven without HIV-related neurological pathology, and of 25 HIV-negative control subjects with other neurological diseases. The cerebrospinal LTB4 level was increased in all the AIDS patients (mean 348 pg/ml); the control group revealed normal levels of LTB4 in the CSF (mean 63.2 pg/ml). The PGD2 level in the HIV-positive (mean 264 pg/ml) patients was higher than of the control subjects (mean 50 pg/ml), while low LTC4 levels were found both in the HIV-positive and control groups. We did not find any significant concentration of H in the CSF of either the HIV-positive or the control subjects. These findings may be due to the presence of chronic HIV infection or to the opportunistic infections of the CNS that so often occur in the latest stages of the disease.",
keywords = "Cerebrospinal fluid, Human immunodeficiency virus, Leukotriene B",
author = "M. Froldi and A. Castagna and M. Parma and A. Piona and A. Tedeschi and A. Miadonna and M. Lorini and {Nobile Orazio}, E. and A. Lazzarin",
year = "1992",
doi = "10.1016/0165-5728(92)90100-Y",
language = "English",
volume = "38",
pages = "155--161",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier Science B.V.",
number = "1-2",

}

TY - JOUR

T1 - Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement

AU - Froldi, M.

AU - Castagna, A.

AU - Parma, M.

AU - Piona, A.

AU - Tedeschi, A.

AU - Miadonna, A.

AU - Lorini, M.

AU - Nobile Orazio, E.

AU - Lazzarin, A.

PY - 1992

Y1 - 1992

N2 - In this study we evaluated the release of some mediators of inflammatory reactions such as histamine (H), leukotriene B4 (LTB4) leukotriene C4 (LTC4) and prostaglandin D2 (PGD2) in the cerebrospinal fluid (CSF) of 15 patients with acquired immunodeficiency syndrome (AIDS), eight with opportunistic infections of the central nervous system (CNS) and seven without HIV-related neurological pathology, and of 25 HIV-negative control subjects with other neurological diseases. The cerebrospinal LTB4 level was increased in all the AIDS patients (mean 348 pg/ml); the control group revealed normal levels of LTB4 in the CSF (mean 63.2 pg/ml). The PGD2 level in the HIV-positive (mean 264 pg/ml) patients was higher than of the control subjects (mean 50 pg/ml), while low LTC4 levels were found both in the HIV-positive and control groups. We did not find any significant concentration of H in the CSF of either the HIV-positive or the control subjects. These findings may be due to the presence of chronic HIV infection or to the opportunistic infections of the CNS that so often occur in the latest stages of the disease.

AB - In this study we evaluated the release of some mediators of inflammatory reactions such as histamine (H), leukotriene B4 (LTB4) leukotriene C4 (LTC4) and prostaglandin D2 (PGD2) in the cerebrospinal fluid (CSF) of 15 patients with acquired immunodeficiency syndrome (AIDS), eight with opportunistic infections of the central nervous system (CNS) and seven without HIV-related neurological pathology, and of 25 HIV-negative control subjects with other neurological diseases. The cerebrospinal LTB4 level was increased in all the AIDS patients (mean 348 pg/ml); the control group revealed normal levels of LTB4 in the CSF (mean 63.2 pg/ml). The PGD2 level in the HIV-positive (mean 264 pg/ml) patients was higher than of the control subjects (mean 50 pg/ml), while low LTC4 levels were found both in the HIV-positive and control groups. We did not find any significant concentration of H in the CSF of either the HIV-positive or the control subjects. These findings may be due to the presence of chronic HIV infection or to the opportunistic infections of the CNS that so often occur in the latest stages of the disease.

KW - Cerebrospinal fluid

KW - Human immunodeficiency virus

KW - Leukotriene B

UR - http://www.scopus.com/inward/record.url?scp=0026554103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026554103&partnerID=8YFLogxK

U2 - 10.1016/0165-5728(92)90100-Y

DO - 10.1016/0165-5728(92)90100-Y

M3 - Article

VL - 38

SP - 155

EP - 161

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -